Document Type : Original Research


1 Department of Radiology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Department of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Urology, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran

4 Nephrology Research Center, Tehran University of Medical Science, Tehran, Iran


Background & Objective: The prevalence of glomerular diseases, as the leading cause of chronic kidney disease, is increasing. Renal biopsy is still the gold standard for diagnosis of the most kidney disorders. Data on prevalence of the biopsy-proven kidney diseases in Iran is limited and none of the previously reported studies used electron microscopic (EM) evaluation for the diagnosis. This study was conducted to analyze the prevalence of biopsy-proven kidney diseases in a referral center in Iran.
Methods: The reports of kidney biopsy samples from 2006 to 2018 referred to a pathology center, affiliated with Tehran University of Medical Sciences were reviewed. The prevalence of different disorders was assessed based on the clinical presentation in 3 age categories, including childhood, adulthood, and elderly.
Results: Among 3455 samples, 2975 were analyzed after excluding transplant-related specimens, suboptimal specimens, and those with uncertain diagnoses. Nephrotic syndrome (NS) (39%) was the most common cause of biopsy followed by subnephrotic proteinuria (18%), hematuria in association with proteinuria (15%), renal failure (9%), isolated hematuria (6%), lupus (4%) and the other non-specific manifestations such as hypertetion or malaise (each one less than 2%). The most common diagnoses included membranous nephropathy (MGN) (17.9%), focal segmental glomerulosclerosis (FSGS) (15.9%), lupus nephritis (LN) (13.7%), minimal histopathological findings (unsampled FSGS versus Minimal Change Disease, 12.1%), Immunoglobulin-A (IgA) nephropathy (6.5%) and Alport syndrome (6.1%). MGN was the most frequent disease before 2013, but FSGS became more frequent after that.
Conclusion: NS and proteinuria were the most indications for kidney biopsy. Although MGN was the most common disease, the prevalence of FSGS has been increasing in recent years and making it the most common disease after 2013. LN and IgA nephropathy are the most common causes of secondary and primary GN presenting with proteinuria and hematuria, respectively.


Main Subjects

  1. Li Y, Ning Y, Shen B, Shi Y, Song N, Fang Y, et al. Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Clin Kidney J. 2023;16(2):312-21. [DOI:10.1093/ckj/sfac218] [PMID] [PMCID]
  2. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019;1165:3-15. [DOI:10.1007/978-981-13-8871-2_1] [PMID]
  3. Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, et al. Trends in Prevalence of Chronic Kidney Disease in the United States. Ann Intern Med. 2016;165(7):473-81. [DOI:10.7326/M16-0273] [PMID] [PMCID]
  4. Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease-a systematic review and meta-analysis. PloS one. 2016;11(7):e0158765. [DOI:10.1371/journal.pone.0158765] [PMID] [PMCID]
  5. Fiorentino M, Bolignano D, Tesar V, Pisano A, Van Biesen W, D'Arrigo G, et al. Renal Biopsy in 2015--From Epidemiology to Evidence-Based Indications. Am J Nephrol. 2016;43(1):1-19. [DOI:10.1159/000444026] [PMID]
  6. Bouya S, Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta-Analysis and Systematic Review. Ther Apher Dial. 2018;22(6):594-9. [DOI:10.1111/1744-9987.12716] [PMID]
  7. Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circulation Res. 2023;132(8):1050-63. [DOI:10.1161/CIRCRESAHA.122.321762] [PMID]
  8. Nili F, Saboori F, Jahanzad I, Mehrazma M. Electron microscopic findings suggestive of focal and segmental glomerulosclerosis in patients with steroid-resistant nephrotic syndrome. Ultrastruct Pathol. 2019;43(1):6-12. [DOI:10.1080/01913123.2019.1584258] [PMID]
  9. Cunningham A, Benediktsson H, Muruve DA, Hildebrand AM, Ravani P. Trends in Biopsy-Based Diagnosis of Kidney Disease: A Population Study. Can J Kidney Health Dis. 2018;5:2054358118799690. [DOI:10.1177/2054358118799690] [PMID] [PMCID]
  10. Hou JH, Zhu HX, Zhou ML, Le WB, Zeng CH, Liang SS, et al. Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China. Kidney Dis (Basel). 2018;4(1):10-9. [DOI:10.1159/000484717] [PMID] [PMCID]
  11. Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66(3):920-3. [DOI:10.1111/j.1523-1755.2004.00837.x] [PMID]
  12. Naini AE, Harandi AA, Ossareh S, Ghods A, Bastani B. Prevalence and clinical findings of biopsy-proven glomerulonephritidis in Iran. Saudi J Kidney Dis Transpl. 2007;18(4):556-64.
  13. Daneshpajouhnejad P, Behzadi E, Amoushahi S, Aghabozorgi A, Farmani A, Hosseini SM, et al. A six-year survey of the spectrum of renal disorders on native kidney biopsy results in Central Iran and a review of literature. Saudi J Kidney Dis Transpl. 2018;29(3):658-70. [DOI:10.4103/1319-2442.235191] [PMID]
  14. Wiles K, Lightstone L. Glomerular Disease in Women. Kidney Int Rep. 2018;3(2):258-70. [DOI:10.1016/j.ekir.2018.01.010] [PMID] [PMCID]
  15. Lai WL, Yeh TH, Chen PM, Chan CK, Chiang WC, Chen YM, et al. Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment. J Formos Med Assoc. 2015;114(2):102-11. [DOI:10.1016/j.jfma.2014.11.002] [PMID]
  16. Couser WG. Primary Membranous Nephropathy. Clin J Am Soc Nephrol. 2017;12(6):983-97. [DOI:10.2215/CJN.11761116] [PMID] [PMCID]
  17. Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997;30(5):621-31. [DOI:10.1016/S0272-6386(97)90485-6] [PMID]
  18. Haas M, Spargo BH, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis. 1995;26(5):740-50. [DOI:10.1016/0272-6386(95)90437-9] [PMID]
  19. Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, et al. Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant. 2009;24(8):2406-10. [DOI:10.1093/ndt/gfp091] [PMID]
  20. Jafari M, Monsef A, Soleimani B. Age and gender distribution of primary and secondary glomerulonephritis obtained by renal biopsy: A study from Hamadan, a great province in Western Iran. Saudi J Kidney Dis and Transplant. 2015;26(2):375. [DOI:10.4103/1319-2442.152542] [PMID]
  21. Ossareh S, Asgari M, Abdi E, Nejad-Gashti H, Ataipour Y, Aris S, et al. Renal biopsy findings in Iran: case series report from a referral kidney center. Int Urol Nephrol. 2010;42(4):1031-40. [DOI:10.1007/s11255-009-9684-0] [PMID]
  22. Mohammadhoseiniakbari H, Rezaei N, Rezaei A, Roshan SK, Honarbakhsh Y. Pattern of glomerulonephritis in Iran: a preliminary study and brief review. Med Sci Monit. 2009;15(9):PH109-14.
  23. Dragovic D, Rosenstock JL, Wahl SJ, Panagopoulos G, DeVita MV, Michelis MF. Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns. Clin Nephrol. 2005;63(1):1-7. [DOI:10.5414/CNP63001] [PMID]
  24. Hong W, Ren Y-l, Chang J, Luo G, Ling-Yun S. A systematic review and meta-analysis of prevalence of biopsy-proven lupus nephritis. Arch Rheumatol. 2018;33(1):17. [DOI:10.5606/ArchRheumatol.2017.6127] [PMID] [PMCID]
  25. Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2017;12(5):825-35. [DOI:10.2215/CJN.05780616] [PMID] [PMCID]
  26. Wester DC, Atkin CL, Gregory MC. Alport syndrome: clinical update. J Am Acad Audiol. 1995;6(1):73-9.
  27. Perkowska-Ptasinska A, Deborska-Materkowska D, Bartczak A, Stompor T, Liberek T, Bullo-Piontecka B, et al. Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland. BMC Nephrol. 2016;17(1):194. [DOI:10.1186/s12882-016-0410-8] [PMID] [PMCID]
  28. Yang Y, Zhang Z, Zhuo L, Chen DP, Li WG. The Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review. Chin Med J (Engl). 2018;131(6):731-5. [DOI:10.4103/0366-6999.226906] [PMID] [PMCID]
  29. Das U, Dakshinamurty KV, Prayaga A. Pattern of biopsy-proven renal disease in a single center of south India: 19 years experience. Indian J Nephrol. 2011;21(4):250-7. [DOI:10.4103/0971-4065.85482] [PMID] [PMCID]

30. O'Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC. Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dialysis Transplant. 2017;33(4):661-9. [DOI:10.1093/ndt/gfx189] [PMID] [PMCID]